Cabaletta Bio, Inc.

CABA · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$44,866-$45,128-$35,943-$32,586
Dep. & Amort.$345$468$485$468
Deferred Tax$0$0$0$0
Stock-Based Comp.$5,815$5,705$5,161$0
Change in WC$215$4,065-$3,047$2,874
Other Non-Cash$3,982$4,464$2,542$6,122
Operating Cash Flow-$34,509-$30,426-$30,802-$23,122
Investing Activities
PP&E Inv.-$78-$161-$785-$376
Net Acquisitions$0$0$0$0
Inv. Purchases-$50,002-$49,035$0$0
Inv. Sales/Matur.$0$0$0$12,500
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$50,080-$49,196-$785$12,124
Financing Activities
Debt Repay.-$795-$3,002-$552-$897
Stock Issued-$25$96,178$0$5,269
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$14$197$0$0
Financing Cash Flow-$806$93,373-$552$4,372
Forex Effect-$11$31$7-$20
Net Chg. in Cash-$85,406$13,782-$32,132-$6,646
Supplemental Information
Beg. Cash$145,612$131,830$163,962$170,608
End Cash$60,206$145,612$131,830$163,962
Free Cash Flow-$34,587-$30,587-$31,587-$23,498
Cabaletta Bio, Inc. (CABA) Financial Statements & Key Stats | AlphaPilot